Showing 361-370 of 1066 results for "".
- Uncovering the Cause of Neuropathyhttps://practicalneurology.com/diseases-diagnoses/neuromuscular/PN0305FeaNeuropathy-pdf/31482/Asymmetric Neuropathies: Diverse Etiologies and Clinical ApproachesAsymmetric neuropathy represents a significant referral reason to neurologists, contrasting with the more common symmetric, length-dependent variants. This condition encompasses a broad differential diagnosis, often presenting treata
- Making the Switch: When and How to Step-Up MS Therapyhttps://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/PN1108MS-pdf/30974/Advancements and Considerations in Multiple Sclerosis TherapeuticsOver the past quarter-century, Multiple Sclerosis (MS) treatment has evolved rapidly, marked by the FDA approval of six disease-modifying therapies (DMTs) with several more in development. This acceleration contrasts with the decade-l
- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31004/Malignant Hyperthermia: Clinical Insights and ManagementMalignant hyperthermia (MH) is a rare, life-threatening hypermetabolic neuromuscular disorder predominantly triggered by specific anesthetic agents in susceptible individuals, often presenting during general anesthesia. A notable case involved
- The Fine Art of Managing Peripheral Nerve Injurieshttps://practicalneurology.com/columns/practice-management/the-fine-art-of-managing-peripheral-nerve-injuries/31102/Peripheral nerve injuries present a complex challenge in neurology, requiring precise diagnosis and tailored management to optimize patient outcomes. These injuries are broadly classified into two categories: transection and neuroma-in-continuity. Transection involves a complete severance of the ner
- Can We Boost The Efficacy of Dopaminergic Therapy?https://practicalneurology.com/columns/practice-management/can-we-boost-the-efficacy-of-dopaminergic-therapy/31220/Parkinson’s disease (PD) management continues to prioritize maintaining patients' quality of life and motor function, aligning with the foundational goals established since Dr. James Parkinson’s initial descriptions in 1817. Contemporary treatment primarily focuses on dopamine replacement to counter
- The Tug-of-War Over Medical Liability Reformhttps://practicalneurology.com/columns/practice-management/the-tug-of-war-over-medical-liability-reform/31279/The ongoing struggle over medical liability reform in the United States remains a critical issue for healthcare professionals, particularly within the field of neurology. Physicians across various specialties face increasing malpractice insurance premiums and the pressures of defensive medicine, dri
- The Good, the Bad and the Ugly of Alternative Medicinehttps://practicalneurology.com/columns/practice-management/the-good-the-bad-and-the-ugly-of-alternative-medicine/31299/Alternative Medicine in Neurology: Navigating Patient Use and Clinical ImplicationsThe June 2006 issue of *Practical Neurology* addresses the rising prominence of alternative medicine within the neurological patient population, underscored by the bestselling yet controversial book by Kevin Trudeau.
- Searching for the Connections Between PFO, Stroke and Migrainehttps://practicalneurology.com/diseases-diagnoses/stroke/pn0406-pfo-pdf/31321/Patent Foramen Ovale: Implications for Stroke and Migraine ManagementRecent advancements in neurology have intensified the focus on patent foramen ovale (PFO), a heart defect present in approximately 40 million Americans. Although many individuals with PFO remain asymptomatic, emerging research sugg
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31400/Recent advancements in Alzheimer’s disease (AD) research are shedding light on its elusive etiology and pathophysiology, offering new insights for healthcare professionals. A significant study published in the *American Journal of Industrial Medicine* analyzed 2.6 million death records from 22 state
- Intervention Can't Be Justified Without More Precise Patient Selectionhttps://practicalneurology.com/columns/practice-management/intervention-cant-be-justified-without-more-precise-patient-selection/31408/Carotid stenosis management remains a debated topic in neurology, particularly concerning asymptomatic carotid stenosis (ACS). The number needed to treat (NNT), as introduced by Laupacis et al., serves as a crucial metric in determining the effectiveness and cost-efficiency of interventions. For pat